HistoryOrchid Cellmark was created from the combination of two of the most experienced nationwide paternity testing firms in the industry. Our experience in the field of paternity testing dates back to 1979 and includes many industry firsts, like the development and early application of DNA technology to both paternity and forensic testing.
Orchid BioSciences, Inc.
Orchid BioSciences, Inc., one of the largest providers of identity DNA testing services in the world, markets its paternity testing services under the Orchid Cellmark name. In the human identity area, Orchid BioSciences provides DNA testing services for forensic, family relationship and security applications. In the agriculture field, Orchid BioSciences provides DNA testing services for food safety and selective trait breeding. Orchid BioSciences’ strong market positions in these segments reflect the company’s accredited laboratories in the U.S. and U.K., its innovative genetic analysis technologies and expertise, and its reputation for exceptional quality, reliability and customer service. More information on Orchid can be found at www.orchid.com.
As part of Orchid BioSciences, Orchid Cellmark has access to cutting edge DNA analysis technology including the recent development of a powerful new class of genetic markers called single nucleotide polymorphisms or SNPs. Orchid BioSciences was the first laboratory to receive approval from the American Association of Blood Banks to use SNPs on a standalone basis for paternity testing. Orchid BioSciences has used this same technology in its groundbreaking efforts to help identify the remains from the 9/11 World Trade Center disaster.
PRINCETON, N.J., Nov. 1, 2001 /PRNewswire/ --
Orchid BioSciences, Inc. (Nasdaq: ORCH ORCH Orchestra ORCH Orchard ) will release its third quarter financial results at 7 a.m. ET on Thursday, November 8, 2001 and is hosting a conference call that will be broadcast live over the Internet that day at 10 a.m. ET. Participating members of senior management include Dale Pfost, Ph.D., chairman, president and chief executive officer, and Donald Marvin, chief financial officer and chief operating officer Chief Operating Officer (COO)
The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. . Management will discuss financial results for the quarter and Orchid's recent operating highlights. A question-and-answer session will follow management's discussion.
What: Orchid BioSciences, Inc. Third Quarter Financial Results
Conference Call
When: Thursday, November 8, 2001, 10 a.m. ET
How: The dial-in number for domestic callers is 888-328-2943 and for international callers is 212-346-6428.
A live Webcast of the conference call and a replay will also be section of the company's website at www.orchid.com. The live conference call as well as the live and archived Webcast are available to all interested parties.
The process by which the corporation communicates with its investors.
Orchid BioSciences, Inc. is a leading provider of products, services and technologies for SNP SNP Scottish National Party
Noun 1. SNP - (genetics) genetic variation in a DNA sequence that occurs when a single nucleotide in a genome is altered; SNPs are usually considered to be point mutations that have been evolutionarily scoring and genetic diversity analyses. Orchid has developed SNP-IT(TM), its proprietary SNP analysis technology, and markets SNPstream(R) instruments and SNPware(TM) consumables that rapidly generate highly accurate, cost-effective SNP information. SNP-IT is usable in environments ranging from small-scale laboratories to large commercial facilities. The versatility of SNP-IT is enabling Orchid to partner with industry leaders to make SNP-IT-enabled products available on a wide variety of instrument platforms as part of Orchid's Platform Propagation(TM) strategy. Orchid also provides high throughput SNP scoring services to pharmaceutical, biotechnology, agricultural and academic customers through its MegaSNPatron(TM) facilities, and identity genomics testing for forensics and paternity The state or condition of a father; the relationship of a father.
English and U.S. Common Law have recognized the importance of establishing the paternity of children. , as well as clinical quality genotyping, through its GeneScreen and Cellmark units. Orchid also provides content-rich SNP databases and SNP panels to its customers and collaborators. Through its GeneShield business, Orchid seeks to identify and commercialize medical applications of SNPs. More information on Orchid and on the proposed acquisition of Lifecodes can be found at its web site www.orchid.com.
Orchid BioSciences, Inc. (Nasdaq: ORCH ORCH Orchestra ORCH Orchard ) will release its third quarter financial results at 7 a.m. ET on Thursday, November 8, 2001 and is hosting a conference call that will be broadcast live over the Internet that day at 10 a.m. ET. Participating members of senior management include Dale Pfost, Ph.D., chairman, president and chief executive officer, and Donald Marvin, chief financial officer and chief operating officer Chief Operating Officer (COO)
The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. . Management will discuss financial results for the quarter and Orchid's recent operating highlights. A question-and-answer session will follow management's discussion.
What: Orchid BioSciences, Inc. Third Quarter Financial Results
Conference Call
When: Thursday, November 8, 2001, 10 a.m. ET
How: The dial-in number for domestic callers is 888-328-2943 and for international callers is 212-346-6428.
A live Webcast of the conference call and a replay will also be section of the company's website at www.orchid.com. The live conference call as well as the live and archived Webcast are available to all interested parties.
The process by which the corporation communicates with its investors.
Orchid BioSciences, Inc. is a leading provider of products, services and technologies for SNP SNP Scottish National Party
Noun 1. SNP - (genetics) genetic variation in a DNA sequence that occurs when a single nucleotide in a genome is altered; SNPs are usually considered to be point mutations that have been evolutionarily scoring and genetic diversity analyses. Orchid has developed SNP-IT(TM), its proprietary SNP analysis technology, and markets SNPstream(R) instruments and SNPware(TM) consumables that rapidly generate highly accurate, cost-effective SNP information. SNP-IT is usable in environments ranging from small-scale laboratories to large commercial facilities. The versatility of SNP-IT is enabling Orchid to partner with industry leaders to make SNP-IT-enabled products available on a wide variety of instrument platforms as part of Orchid's Platform Propagation(TM) strategy. Orchid also provides high throughput SNP scoring services to pharmaceutical, biotechnology, agricultural and academic customers through its MegaSNPatron(TM) facilities, and identity genomics testing for forensics and paternity The state or condition of a father; the relationship of a father.
English and U.S. Common Law have recognized the importance of establishing the paternity of children. , as well as clinical quality genotyping, through its GeneScreen and Cellmark units. Orchid also provides content-rich SNP databases and SNP panels to its customers and collaborators. Through its GeneShield business, Orchid seeks to identify and commercialize medical applications of SNPs. More information on Orchid and on the proposed acquisition of Lifecodes can be found at its web site www.orchid.com.
PRINCETON, N.J., July 31 /PRNewswire/ Orchid BioSciences, Inc.
(Nasdaq: ORCH ORCH Orchestra
ORCH Orchard ) will release its second quarter financial results at 7 a.m. ET on Tuesday, August 7, 2001 and is hosting a conference call that will be broadcast live over the Internet that day at 10 a.m., ET. Participating members of senior management include Dale Pfost, Ph.D., chairman, president and chief executive officer, and Donald Marvin, chief financial officer and chief operating officer Chief Operating Officer (COO)
The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. . Management will discuss financial results for the quarter and Orchid's recent operating highlights. A question-and-answer session will follow.
What: Orchid BioSciences, Inc. Second Quarter Financial
Results Conference Call
ORCH Orchard ) will release its second quarter financial results at 7 a.m. ET on Tuesday, August 7, 2001 and is hosting a conference call that will be broadcast live over the Internet that day at 10 a.m., ET. Participating members of senior management include Dale Pfost, Ph.D., chairman, president and chief executive officer, and Donald Marvin, chief financial officer and chief operating officer Chief Operating Officer (COO)
The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. . Management will discuss financial results for the quarter and Orchid's recent operating highlights. A question-and-answer session will follow.
What: Orchid BioSciences, Inc. Second Quarter Financial
Results Conference Call
When: Tuesday, August 7, 2001, 10 a.m. ET
How: The dial-in number for domestic callers is 800-263-9155 and for international callers is 212-676-4910.
A replay of the conference call will be available
21. The replay number for domestic callers is 800-633-8284, and for international callers is 858-812-6440, reservation number 19398334.
A live Webcast of the conference call and a replay will also be available at the Investor Relations Investor relations
The process by which the corporation communicates with its investors. section of the company's website at
http://www.orchid.com. The conference call, replay and Webcast are available to all interested parties.
Orchid BioSciences, Inc. is a leading provider of products, services and technologies for SNP SNP Scottish National Party
Noun 1. SNP - (genetics) genetic variation in a DNA sequence that occurs when a single nucleotide in a genome is altered; SNPs are usually considered to be point mutations that have been evolutionarily (single nucleotide polymorphism Noun 1. single nucleotide polymorphism - (genetics) genetic variation in a DNA sequence that occurs when a single nucleotide in a genome is altered; SNPs are usually considered to be point mutations that have been evolutionarily successful enough to recur in a ) scoring and genetic diversity analyses. Orchid has developed SNP-IT(TM), its proprietary SNP analysis technology, and markets SNPstream(R) instruments and SNPware(TM) consumables that rapidly generate highly accurate, cost effective SNP information. SNP-IT is usable in environments ranging from small-scale laboratories to large commercial facilities. Its versatility is enabling Orchid to partner with industry leaders to make SNP-IT-enabled products available on a wide variety of instrument platforms as part of Orchid's Platform Propagation(TM) strategy. Orchid provides high throughput SNP scoring services to pharmaceutical, biotechnology and academic customers through its MegaSNPatron(TM) facilities, and DNA testing through its GeneScreen and Cellmark facilities that conduct paternity The state or condition of a father; the relationship of a father.
English and U.S. Common Law have recognized the importance of establishing the paternity of children. and forensics testing, as well as clinical pharmacogenetic testing. Orchid also provides content-rich SNP databases and SNP panels to its customers and collaborators. Through its Pharmaceutical Value Creation(TM) business, Orchid seeks to identify proprietary medical applications of SNPs. More information on Orchid can be found at its web site http://www.orchid.com.
Contact: Orchid BioSciences, Inc.
609-750-2200
Lisa D. Mackin
Corporate Communications
How: The dial-in number for domestic callers is 800-263-9155 and for international callers is 212-676-4910.
A replay of the conference call will be available
21. The replay number for domestic callers is 800-633-8284, and for international callers is 858-812-6440, reservation number 19398334.
A live Webcast of the conference call and a replay will also be available at the Investor Relations Investor relations
The process by which the corporation communicates with its investors. section of the company's website at
http://www.orchid.com. The conference call, replay and Webcast are available to all interested parties.
Orchid BioSciences, Inc. is a leading provider of products, services and technologies for SNP SNP Scottish National Party
Noun 1. SNP - (genetics) genetic variation in a DNA sequence that occurs when a single nucleotide in a genome is altered; SNPs are usually considered to be point mutations that have been evolutionarily (single nucleotide polymorphism Noun 1. single nucleotide polymorphism - (genetics) genetic variation in a DNA sequence that occurs when a single nucleotide in a genome is altered; SNPs are usually considered to be point mutations that have been evolutionarily successful enough to recur in a ) scoring and genetic diversity analyses. Orchid has developed SNP-IT(TM), its proprietary SNP analysis technology, and markets SNPstream(R) instruments and SNPware(TM) consumables that rapidly generate highly accurate, cost effective SNP information. SNP-IT is usable in environments ranging from small-scale laboratories to large commercial facilities. Its versatility is enabling Orchid to partner with industry leaders to make SNP-IT-enabled products available on a wide variety of instrument platforms as part of Orchid's Platform Propagation(TM) strategy. Orchid provides high throughput SNP scoring services to pharmaceutical, biotechnology and academic customers through its MegaSNPatron(TM) facilities, and DNA testing through its GeneScreen and Cellmark facilities that conduct paternity The state or condition of a father; the relationship of a father.
English and U.S. Common Law have recognized the importance of establishing the paternity of children. and forensics testing, as well as clinical pharmacogenetic testing. Orchid also provides content-rich SNP databases and SNP panels to its customers and collaborators. Through its Pharmaceutical Value Creation(TM) business, Orchid seeks to identify proprietary medical applications of SNPs. More information on Orchid can be found at its web site http://www.orchid.com.
Contact: Orchid BioSciences, Inc.
609-750-2200
Lisa D. Mackin
Corporate Communications
No comments:
Post a Comment